Market Cap

As of July 16, 2010: $14,566,000.00

Stock Chart

GeneticTech - 30 Day Poll

Recent BLOGS About GeneticTech Add New

There are no blogs to display.

Latest Company News

Australia - Beef groups
Meattradenewsdaily - Jul 26, 2010
The groups are facilitated by the Department of Agriculture and Food, as part of the Cooperative Research Centre for Beef Genetic Technologies accelerated adoption programme. Department ...
Minnesota Partnership Funds Mobile Obesity Lab, Genetic Technology
PharmaLive - Jul 19, 2010
ROCHESTER/MINNEAPOLIS, Minn., July 19, 2010 — The Minnesota Partnership is helping scientists bring obesity research to the people of the state. An obesity research "laboratory on wheels ...
Australia challenge ignited by the US success in invalidating patents on cancer gene
Lexology - Jul 15, 2010
Following from the recent significant decision by the US New York's District Court which, as we reported in our April edition, held that Myriad Genetic Inc.'s (Myriad) patents on DNA sequences ...
The Genetic Information Nondiscrimination Act (GINA): How PAs can protect patients and their families
Journal of the American Academy of Physician Assistants - Jul 14, 2010
Rachel, a 39-year-old woman, presents to her family practice PA after finding a mass in the upper outer quadrant of her right breast. She is referred to an oncologist for evaluation and undergoes ...
I'm pleased to announce the beta launch of a new group blog on personal genomics, Genomes Unzipped.
ScienceBlogs - Jul 12, 2010
I've been working with a group of scientific colleagues and fellow bloggers on this project for quite a while now. Some of the group members will be familiar to regular readers: Dan Vorhaus from ...
Genetic patenting push needs to keep sight of public interest
Sydney Morning Herald - Jul 5, 2010
Should genes be patented? The Australian Senate was due to report in June, but the issue is so complex that it has extended its reporting deadline yet again. The issue involves the complex legal ...
Colombia - Pig genetics
Meattradenewsdaily - Jun 30, 2010
Newsham Choice Genetics, a worldwide leader in swine genetic technology, has partnered with Solla, a Medellin, Colombia-based multispecies nutrition company, to establish nucleus herds using ...
GTG Extends Quest Diagnostics Non-Coding License
Drug Discovery & Development - Jun 29, 2010
Genetic Technologies Limited has executed an amendment to the original Non-Coding License Agreement of August 2003 granted to Quest Diagnostics Inc. based in San Clemente, California. This is now ...

Website

Videos related to GeneticTech

Company Profile

Genetic Technologies (ASX: GTG, NASDAQ Global Market: GENE) is a genetic testing and reproductive services business which, together with a range of international patents and allied research activities, aims at uncovering the impact of DNA on health. The Company’s principal activities include the provision of genetic testing services and canine reproductive services.


Throughout the Asia Pacific region, they translate specialised genetic tests into products and services that optimise the health knowledge and outcomes in humans, animals and plants.  

A strong patetnt position?


They have filed a patent infringement suits against nine U.S. biotechnology companies, including Bechman Coulter and Monsanto (Tier 1 organizsations). The patent at the centre of the suit refers to non-coding DNA technologies that Genetic Technologies claims are being used by the biotech firms without license. The counter-parties in the suit are Beckman Coulter, Orchid Cellmark, Gen-Probe, Interleukin Genetics, Molecular Pathology Laboratory Network, Monsanto, PIC USA, Sunrise Medical Laboratories and Pioneer Hi-Bred International. The non-coding DNA technology in question is already licensed to 39 other companies.



In 2008 Genetic Technologies stirred up controversy by demanding several Australian labs cease performing a test for the breast cancer genes BRCA1 and BRCA2 for which the company held an exclusive license. Genetic Technologies later withdrew the threat and allowed testing for the genes to continue. The company has been successful in other patent infringement suits, such as in 2005 against Applera Corporation (now ABI Biosystems).


Total revenue and income ($m)
 2006: $10.39
 2007: $10.76
 2008: $15.32
 2009: $15.98 (net loss after tax $7.86M)


Terms & Rules

As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use

Before using this Biomedical Investing website

OR